secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0001157523-22-000502
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra CFO Joshua Reed resigns; Bruce Greenberg named interim CFO
------------------------------------------------------------------

- Joshua Reed resigns as CFO and Treasurer effective May 10, 2022, to pursue other opportunities.
- Bruce Greenberg, current VP and Controller, appointed Interim CFO and Treasurer.
- Greenberg has over 25 years of accounting experience; previously Corporate Controller at Karyopharm Therapeutics.
- Reed will assist transition and participate in Aldeyra's Q1 2022 earnings call.
- No disputes with management or board regarding Reed's resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000115752322000502/0001157523-22-000502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000115752322000502/a52701292.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-000502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer